Literature DB >> 28042509

Ubiquitin-specific protease 11 (USP11) functions as a tumor suppressor through deubiquitinating and stabilizing VGLL4 protein.

Encheng Zhang1, Bing Shen1, Xingyu Mu1, Yan Qin1, Fang Zhang1, Yong Liu1, Jiantao Xiao1, Pingzhao Zhang2, Chenji Wang2, Mingyue Tan1, Yu Fan1.   

Abstract

VGLL4 is a transcriptional repressor that interacts with transcription factors TEADs and inhibits YAP-induced overgrowth and tumorigenesis. VGLL4 protein was dramatically reduced in various types of human cancers. But how VGLL4 protein is post-transcriptional regulated is poorly understood. In this study, we identify deubiquitinating enzyme USP11 as a novel VGLL4 interactor. We reveal that the USP domain of USP11 and the N-terminal region of VGLL4 are required for mutual binding. USP11 controls VGLL4 protein stability by promoting its deubiquitination. Furthermore, our results show that knockdown of USP11 promotes cell growth, migration, and invasion in a YAP-dependent manner. Together, our results suggest that USP11 may exert its tumor suppressor role by modulating VGLL4/YAP-TEADs regulatory loop.

Entities:  

Keywords:  Hippo pathway; TEADs; USP11; VGLL4; deubiquitination

Year:  2016        PMID: 28042509      PMCID: PMC5199763     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  17 in total

Review 1.  Mechanisms underlying ubiquitination.

Authors:  C M Pickart
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

2.  miR-222/VGLL4/YAP-TEAD1 regulatory loop promotes proliferation and invasion of gastric cancer cells.

Authors:  Nan Li; Nanrong Yu; Jia Wang; Haofeng Xi; Weiqun Lu; Houwei Xu; Min Deng; Guopei Zheng; Haiying Liu
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

3.  USP11 regulates p53 stability by deubiquitinating p53.

Authors:  Jia-ying Ke; Cong-jie Dai; Wen-lin Wu; Jin-hua Gao; Ai-juan Xia; Guang-ping Liu; Kao-sheng Lv; Chun-lin Wu
Journal:  J Zhejiang Univ Sci B       Date:  2014-12       Impact factor: 3.066

4.  TEAD mediates YAP-dependent gene induction and growth control.

Authors:  Bin Zhao; Xin Ye; Jindan Yu; Li Li; Weiquan Li; Siming Li; Jianjun Yu; Jiandie D Lin; Cun-Yu Wang; Arul M Chinnaiyan; Zhi-Chun Lai; Kun-Liang Guan
Journal:  Genes Dev       Date:  2008-06-25       Impact factor: 11.361

5.  USP11 negatively regulates TNFalpha-induced NF-kappaB activation by targeting on IkappaBalpha.

Authors:  Wenjing Sun; Xiaojie Tan; Yi Shi; Gufeng Xu; Renfang Mao; Xue Gu; Yihui Fan; Yang Yu; Susan Burlingame; Hong Zhang; Surya P Rednam; Xiongbin Lu; Ting Zhang; Songbin Fu; Guangwen Cao; Jun Qin; Jianhua Yang
Journal:  Cell Signal       Date:  2010-03       Impact factor: 4.315

6.  A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP).

Authors:  Bin Zhao; Li Li; Karen Tumaneng; Cun-Yu Wang; Kun-Liang Guan
Journal:  Genes Dev       Date:  2010-01-01       Impact factor: 11.361

7.  Negative regulation of the Hippo pathway by E3 ubiquitin ligase ITCH is sufficient to promote tumorigenicity.

Authors:  Zaidoun Salah; Gerry Melino; Rami I Aqeilan
Journal:  Cancer Res       Date:  2011-01-06       Impact factor: 12.701

8.  Ubiquitin-specific proteases 7 and 11 modulate Polycomb regulation of the INK4a tumour suppressor.

Authors:  Goedele N Maertens; Selma El Messaoudi-Aubert; Sarah Elderkin; Kevin Hiom; Gordon Peters
Journal:  EMBO J       Date:  2010-07-02       Impact factor: 11.598

Review 9.  Emerging roles of TEAD transcription factors and its coactivators in cancers.

Authors:  Ajaybabu V Pobbati; Wanjin Hong
Journal:  Cancer Biol Ther       Date:  2013-02-04       Impact factor: 4.742

10.  Deubiquitylating enzyme USP9x regulates hippo pathway activity by controlling angiomotin protein turnover.

Authors:  Hung Thanh Nguyen; Diana Andrejeva; Rajat Gupta; Chunaram Choudhary; Xin Hong; Pieter J A Eichhorn; Anand C Loya; Stephen M Cohen
Journal:  Cell Discov       Date:  2016-03-29       Impact factor: 10.849

View more
  15 in total

1.  Loss of VGLL4 suppresses tumor PD-L1 expression and immune evasion.

Authors:  Ailing Wu; Qingzhe Wu; Yujie Deng; Yuning Liu; Jinqiu Lu; Liansheng Liu; Xiaoling Li; Cheng Liao; Bin Zhao; Hai Song
Journal:  EMBO J       Date:  2018-11-05       Impact factor: 11.598

2.  Putting phage to work in deubiquitinase ligand discovery.

Authors:  Julie A Maupin-Furlow
Journal:  J Biol Chem       Date:  2019-01-11       Impact factor: 5.157

3.  Copy number variation of ubiquitin- specific proteases genes in blood leukocytes and colorectal cancer.

Authors:  Tian Tian; Haoran Bi; Yupeng Liu; Guangxiao Li; Yiwei Zhang; Liming Cao; Fulan Hu; Yashuang Zhao; Huiping Yuan
Journal:  Cancer Biol Ther       Date:  2020-05-04       Impact factor: 4.742

Review 4.  VGLL4 is a transcriptional cofactor acting as a novel tumor suppressor via interacting with TEADs.

Authors:  Xiaochong Deng; Lin Fang
Journal:  Am J Cancer Res       Date:  2018-06-01       Impact factor: 6.166

5.  USP11 Enhances TGFβ-Induced Epithelial-Mesenchymal Plasticity and Human Breast Cancer Metastasis.

Authors:  Daniel A Garcia; Christina Baek; M Valeria Estrada; Tiffani Tysl; Eric J Bennett; Jing Yang; John T Chang
Journal:  Mol Cancer Res       Date:  2018-05-03       Impact factor: 5.852

Review 6.  TGF-β signaling pathway mediated by deubiquitinating enzymes.

Authors:  Soo-Yeon Kim; Kwang-Hyun Baek
Journal:  Cell Mol Life Sci       Date:  2018-10-22       Impact factor: 9.261

Review 7.  The role of deubiquitinating enzymes in cancer drug resistance.

Authors:  Parthasaradhireddy Tanguturi; Kye-Seong Kim; Suresh Ramakrishna
Journal:  Cancer Chemother Pharmacol       Date:  2020-03-07       Impact factor: 3.333

8.  Deubiquitylation and stabilization of p21 by USP11 is critical for cell-cycle progression and DNA damage responses.

Authors:  Tanggang Deng; Guobei Yan; Xin Song; Lin Xie; Yu Zhou; Jianglin Li; Xiaoxiao Hu; Zhen Li; Jun Hu; Yibin Zhang; Hui Zhang; Yang Sun; Peifu Feng; Dong Wei; Bin Hu; Jing Liu; Weihong Tan; Mao Ye
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-16       Impact factor: 11.205

9.  Fatty Acid Synthase induced S6Kinase facilitates USP11-eIF4B complex formation for sustained oncogenic translation in DLBCL.

Authors:  Bandish Kapadia; Nahid M Nanaji; Kavita Bhalla; Binny Bhandary; Rena Lapidus; Afshin Beheshti; Andrew M Evens; Ronald B Gartenhaus
Journal:  Nat Commun       Date:  2018-02-26       Impact factor: 14.919

10.  Identification and Characterization of USP7 Targets in Cancer Cells.

Authors:  Anna Georges; Edyta Marcon; Jack Greenblatt; Lori Frappier
Journal:  Sci Rep       Date:  2018-10-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.